Latest Breaking News On - Currax pharmaceuticals treximet - Page 1 : comparemela.com

18 Apr, 2024 Despite positive efficacy data highlighted at AAN 2024, Axsome Therapeutic s ASX-07 will struggle to make significant impact in acute migraine market, says GlobalData .

United statesPzifer nurtec rimegepantPhilippa salterAbbvie ubrelvyAmerican academy of neurologyCurrax pharmaceuticals treximetAmerican academyAxsome therapeuticsSeniorneurology analystCurrax pharmaceuticals